FindTrial
Sign In

Study on the effect of acupuncture on improving chronic neck pain with mild to moderate anxiety by regulating cortical excitability

Study on the effect of acupuncture on improving chronic pain with anxiety by regulating cortical excitability

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000174
Enrollment
Unknown
Registered
2024-08-05
Start date
2024-08-15
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic neck pain with mild to moderate anxiety disorders

Interventions

Healthy subject group:Inhibit DLPFC, inhibit DLPFC plus acupuncture
Treatment group 1:Conventional acupuncture group
Treatment group 2:Conventional acupuncture combined with Shugan Tiaoshen acupuncture group
Patient group:Inhibit DLPFC, inhibit DLPFC plus acupuncture
Control group:Non-acupoint shallow puncure

Sponsors

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18-60 years old; 2) Healthy volunteers: no physical discomfort or underlying diseases in the past 1 month; Hamilton anxiety scale score HAMA-14=7 points; 3) Patients with chronic neck pain and anxiety: need to meet the diagnostic criteria for chronic neck pain and anxiety; VAS score > 3 and 8< HAMA-14 score =20; 4) no history of needle faintness; 5) No peripheral stimulation intervention (such as acupuncture, peripheral electrical stimulation, etc.) and central stimulation (such as rTMS, tDCS, etc.) in the past three months; 6) Volunteer to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients with cervical spondylosis without cervical pain, or patients without cervical pain as the main complaint; Other types of cervical spondylosis were excluded through clinical manifestations and X-ray examinations. 2) Have violent behavior, psychotic symptoms, or have been diagnosed with schizophrenia, bipolar disorder, or other mental disorders; 3) History of personality disorder; 4) History of alcohol or substance abuse; 5) History of brain trauma and epilepsy; 6) Patients with severe heart, liver, kidney and cerebrovascular diseases; 7) Chronic weakness, severe neurosis, dementia, severe osteoporosis, pregnancy; 8) Leukemia, thrombocytopenia and other bleeding tendency.

Design outcomes

Primary

MeasureTime frame
HAMA scale;NPQ scale;Motor evoked potentials;—

Secondary

MeasureTime frame
SAS scale;VAS scale;—

Countries

China

Contacts

Public ContactJianpeng Huang

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

hopis@sina.com13535175815

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026